<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="brief-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Eur J Nucl Med Mol Imaging</journal-id>
      <journal-title-group>
        <journal-title>European Journal of Nuclear Medicine and Molecular Imaging</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1619-7070</issn>
      <issn pub-type="epub">1619-7089</issn>
      <publisher>
        <publisher-name>Springer-Verlag</publisher-name>
        <publisher-loc>Berlin/Heidelberg</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">21553089</article-id>
      <article-id pub-id-type="pmc">3188706</article-id>
      <article-id pub-id-type="publisher-id">1822</article-id>
      <article-id pub-id-type="doi">10.1007/s00259-011-1822-0</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Image of the Month</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Manifestation of lymphoma expansion following lymphatic drainage on <sup>18</sup>F-FDG PET/CT</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Eshuis</surname>
            <given-names>Silvia A.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Dierckx</surname>
            <given-names>Rudi A. J. O.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>van Snick</surname>
            <given-names>Paul J. H.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Slart</surname>
            <given-names>Riemer H. J. A.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Glaudemans</surname>
            <given-names>Andor W. J. M.</given-names>
          </name>
          <address>
            <email>a.w.j.m.glaudemans@ngmb.umcg.nl</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <aff id="Aff1"><label>1</label>Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands </aff>
        <aff id="Aff2"><label>2</label>Ghent University, Ghent, Belgium </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>7</day>
        <month>5</month>
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>7</day>
        <month>5</month>
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>11</month>
        <year>2011</year>
      </pub-date>
      <volume>38</volume>
      <issue>11</issue>
      <fpage>2100</fpage>
      <lpage>2101</lpage>
      <history>
        <date date-type="received">
          <day>27</day>
          <month>1</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>6</day>
          <month>4</month>
          <year>2011</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2011</copyright-statement>
      </permissions>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Springer-Verlag 2011</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <p><sup>18</sup>F-fluorodeoxyglucose (FDG) positron emission tomography (PET) imaging is strongly recommended in patients with diffuse large B-cell lymphomas (DLBCL), which are routinely highly FDG avid, for adequate disease staging [<xref ref-type="bibr" rid="CR1">1</xref>]. The mean standardized uptake value (SUV) can be used to distinguish aggressive from indolent lymphoma variants [<xref ref-type="bibr" rid="CR2">2</xref>]. PET scanning is a reliable method for the diagnosis of DLBCL compared with the reference method immunohistology [<xref ref-type="bibr" rid="CR3">3</xref>].</p>
    <p>We present a case of a 70-year-old female patient who presented to the hospital with progressive swelling, pain and loss of sensibility in her right lower limb. Nine months earlier she had been diagnosed with DLBLC, localized in the lungs, mediastinum and mesenterium for which she was treated with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) chemotherapy. <sup>18</sup>F-FDG PET/CT scanning was performed for restaging of lymphoma disease in this patient.</p>
    <p><sup>18</sup>F-FDG PET/CT showed an extensive lesion in the right lower limb, with extremely high avidity for FDG, corresponding with tumour mass in muscular tissue on the low-dose CT (figure). It was spreading upwards, following the lymphatic drainage system and surrounding vessels, up to the right groin region. The SUV<sub>mean</sub> of this large lesion was 16.4 (calculation conforming to the EANM procedure guidelines for tumour PET imaging [<xref ref-type="bibr" rid="CR4">4</xref>]). Further on, a lesion was detected dorsally in the right lung.</p>
    <p>Biopsy of the swelling in the right lower limb revealed aggressive DLBCL recurrence. This aggressive form was already expected due to the high SUV<sub>mean</sub> value. This scan shows how aggressive DLBCL can appear as a fast growing lymphoma with an atypical configuration by following the lymphatic drainage.
<graphic position="anchor" xlink:href="259_2011_1822_Figa_HTML" id="MO1"/></p>
  </body>
  <back>
    <ack>
      <p><bold>Conflicts of interest</bold> None.</p>
      <p><bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cheson</surname>
              <given-names>BD</given-names>
            </name>
            <name>
              <surname>Pfistner</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Juweid</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Gascoyne</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Specht</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Horning</surname>
              <given-names>SJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Revised response criteria for malignant lymphoma</article-title>
          <source>J Clin Oncol</source>
          <year>2007</year>
          <volume>25</volume>
          <fpage>579</fpage>
          <lpage>586</lpage>
          <pub-id pub-id-type="doi">10.1200/JCO.2006.09.2403</pub-id>
          <pub-id pub-id-type="pmid">17242396</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Delbeke</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Stroobants</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kerviler</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Gisselbrecht</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Meignan</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Conti</surname>
              <given-names>PS</given-names>
            </name>
          </person-group>
          <article-title>Expert opinions on positron emission tomography and computed tomography imaging in lymphoma</article-title>
          <source>Oncologist</source>
          <year>2009</year>
          <volume>14</volume>
          <issue>Suppl 2</issue>
          <fpage>30</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="doi">10.1634/theoncologist.2009-S2-30</pub-id>
          <pub-id pub-id-type="pmid">19819922</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Friedberg</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Chengazi</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>PET scans in the staging of lymphoma: current status</article-title>
          <source>Oncologist</source>
          <year>2003</year>
          <volume>8</volume>
          <fpage>438</fpage>
          <lpage>447</lpage>
          <pub-id pub-id-type="doi">10.1634/theoncologist.8-5-438</pub-id>
          <pub-id pub-id-type="pmid">14530496</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boellaard</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>O&#x2019;Doherty</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Weber</surname>
              <given-names>WA</given-names>
            </name>
            <name>
              <surname>Mottaghy</surname>
              <given-names>FM</given-names>
            </name>
            <name>
              <surname>Lonsdale</surname>
              <given-names>MN</given-names>
            </name>
            <name>
              <surname>Stroobants</surname>
              <given-names>SG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0</article-title>
          <source>Eur J Nucl Med Mol Imaging</source>
          <year>2010</year>
          <volume>37</volume>
          <fpage>181</fpage>
          <lpage>200</lpage>
          <pub-id pub-id-type="doi">10.1007/s00259-009-1297-4</pub-id>
          <pub-id pub-id-type="pmid">19915839</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
